Oregon Translational Research Anddrug Development Institute
- Assets
- $6.2m
- Revenue
- $2.0m
- Investments
- $0.0
- Employees
- 6
- Location
- Portland, OR
- Founding
- 02/2008
- Data as of
- 12/2021
- EIN
- 20-8877231
Organization Overview
Oregon Translational Research Anddrug Development Institute is located in Portland, OR. The organization was established in 2008. According to its NTEE Classification (B19) the organization is classified as: Support N.E.C., under the broad grouping of Education and related organizations. As of 12/2021, Oregon Translational Research Anddrug Development Institute employed 6 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Oregon Translational Research Anddrug Development Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Oregon Translational Research Anddrug Development Institute generated $2.0m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 5.1% each year. All expenses for the organization totaled $1.7m during the year ending 12/2021. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
OTRADI IS A NON-PROFIT RESEARCH AND DEVELOPMENT ORGANIZATION, SUPPORTED IN PART BY THE STATE OF OREGON, THAT STRIVES TO PROMOTE BIOSCIENCE INDUSTRY GROWTH AND JOB CREATION IN OREGON. OTRADI ACHIEVES THIS GOAL VIA COLLABORATION WITH PRIVATE AND PUBLIC SECTOR ENTITIES IN THE BIOSCIENCE COMMUNITY TO DISCOVER, DEVELOP, AND COMMERCIALIZE THERAPEUTICS, VACCINES, DIAGNOSTICS AND OTHER LIFE SCIENCES PRODUCTS IMPORTANT FOR HUMAN HEALTH.
Describe the Organization's Program Activity:
Part 3 - Line 4a
PROVIDE THE EXPERTISE AND EQUIPMENT REQUIRED TO SUPPORT THE DEVELOPMENT OF THERAPEUTICS AND TECHNOLOGIES ARISING FROM INFECTIOUS DISEASE AND OTHER RESEARCH. PROMOTE BIOSCIENCE SECTOR GROWTH THROUGH COLLABORATION WITH GOVERNMENT, UNIVERSITY, AND PRIVATE ECONOMIC DEVELOPMENT PARTNERS. PROVIDE MENTORING AND INTERNSHIP OPPORTUNITIES FOR STUDENTS, POSTGRADUATES AND OTHER AFFILIATES.
THE OTRADI BIOSCIENCE INCUBATOR IS OREGON'S FIRST BIOSCIENCE SPECIFIC ACCELERATOR. IT PROVIDES SCIENTISTS AND YOUNG COMPANIES WITH THE RESOURCES AND EXPERTISE NEEDED TO TAKE THEIR RESEARCH FROM THE LAB TO THE MARKET.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Heather Ellis Executive Director | Officer | 40 | $140,015 |
Aditi Martin Director | Trustee | 1 | $0 |
Kenneth Wilson Director | Trustee | 1 | $0 |
Frank Curic Director | Trustee | 1 | $0 |
Joseph Janda PHD Board Chair | Trustee | 1 | $0 |
Zach Jonasson PHD Director | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $1,232,800 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $1,232,800 |
| Total Program Service Revenue | $754,476 |
| Investment income | $4,109 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $50,150 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $2,041,535 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $140,015 |
| Compensation of current officers, directors, key employees. | $58,806 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $333,996 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $111,052 |
| Payroll taxes | $38,856 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $15,515 |
| Fees for services: Accounting | $24,488 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $99,224 |
| Advertising and promotion | $4,041 |
| Office expenses | $461 |
| Information technology | $29,938 |
| Royalties | $0 |
| Occupancy | $770,596 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $33,462 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $29,308 |
| Insurance | $30,846 |
| All other expenses | $579 |
| Total functional expenses | $1,724,569 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $3,627,127 |
| Savings and temporary cash investments | $260,464 |
| Pledges and grants receivable | $1,815,001 |
| Accounts receivable, net | $60,372 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $83,211 |
| Net Land, buildings, and equipment | $320,800 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $75,408 |
| Total assets | $6,242,383 |
| Accounts payable and accrued expenses | $129,458 |
| Grants payable | $0 |
| Deferred revenue | $2,200,440 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $152,001 |
| Total liabilities | $2,481,899 |
| Net assets without donor restrictions | $3,760,484 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $6,242,383 |
Grants Recieved
Over the last fiscal year, we have identified 1 grants that Oregon Translational Research Anddrug Development Institute has recieved totaling $85,000.
| Awarding Organization | Amount |
|---|---|
Pharmaceutical Research And Manufacturers Of America Washington, DC PURPOSE: GENERAL CONTRIBUTION | $85,000 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Alliance For College-Ready Public Schools Facilities Corporation Pasadena, CA | $262,311,538 | $18,102,977 |
Associated Students University Of California Davis Business Office Davis, CA | $7,045,095 | $14,137,728 |
Element Education Inc Escondido, CA | $11,446,898 | $15,469,038 |
University Of California Home Loan Program Corporation Oakland, CA | $809,217,947 | $25,322,221 |
California Charter Schools Association Los Angeles, CA | $32,950,225 | $18,898,883 |
Maker Learning Network Acton, CA | $31,041,626 | $6,882,050 |
Pathways Management Group Inc Pasadena, CA | $27,742,984 | $4,110,742 |
Black Girls Code Inc Oakland, CA | $40,729,664 | $16,892,534 |
Manzana Foundation Yakima, WA | $11,655,431 | $2,659,022 |
Washington Software Association Issaquah, WA | $1,165,287 | $5,261,657 |
Silvies River Charter School Crane, OR | $8,476,358 | $7,552,707 |
Gia Holdings Inc Carlsbad, CA | $23,575,400 | $34,356,749 |